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Abstract
The amino acid arginine (Arg) is a recognized secretagogue of growth hormone (GH), and has been shown to induce GH gene 
expression. Arg is the natural precursor of nitric oxide (NO), which is known to mediate many of the effects of Arg, such as GH 
secretion. Arg was also shown to increase calcium influx in pituitary cells, which might contribute to its effects on GH secretion. 
Although the mechanisms involved in the effects of Arg on GH secretion are well established, little is known about them regard-
ing the control of GH gene expression. We investigated whether the NO pathway and/or calcium are involved in the effects of 
Arg on GH gene expression in rat isolated pituitaries. To this end, pituitaries from approximately 170 male Wistar rats (~250 
g) were removed, divided into two halves, pooled (three hemi-pituitaries) and incubated or not with Arg, as well as with different 
pharmacological agents. Arg (71 mM), the NO donor sodium nitroprusside (SNP, 1 and 0.1 mM) and a cyclic guanosine mono-
phosphate (cGMP) analogue (8-Br-cGMP, 1 mM) increased GH mRNA expression 60 min later. The NO acceptor hemoglobin 
(0.3 µM) blunted the effect of SNP, and the combined treatment with Arg and L-NAME (an NO synthase (NOS) inhibitor, 55 mM) 
abolished the stimulatory effect of Arg on GH gene expression. The calcium channel inhibitor nifedipine (3 µM) also abolished 
Arg-induced GH gene expression. The present study shows that Arg directly induces GH gene expression in hemi-pituitaries 
isolated from rats, excluding interference from somatostatinergic neurons, which are supposed to be inhibited by Arg. Moreover, 
the data demonstrate that the NOS/NO signaling pathway and calcium mediate the Arg effects on GH gene expression. 
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Amino acids are essential molecules for protein syn-
thesis, being fundamental for the growth and development 
of all life forms (1). In particular, the amino acid L-arginine 
(Arg) plays a crucial role in nutrition and physiology, as its 
dietary restriction leads to growth delay. This event does not 
seem to be associated with the primary function of amino 
acids as building blocks for proteins, since the restriction of 
some other amino acids does not interfere with this process, 
a fact that reinforces the importance of Arg for growth (2). 
Indeed, Arg was shown to stimulate the secretion of 
hormones that are involved in growth and metabolism, such 
as insulin and growth hormone (GH) (3-8). However, the 
exact mechanism by which Arg stimulates the secretion of 
both hormones is not completely known. 
It has been pointed out that Arg suppresses the release 
of somatostatin (4,7,8), which is known to exert an inhibitory 
effect on insulin and GH secretion. Moreover, Arg treatment 
increased calcium influx in pancreatic beta and pituitary cells 
in culture, suggesting a stimulatory effect on the secretion 
of insulin and GH (9-11). 
It has also been shown that Arg is the natural precursor 
of nitric oxide (NO), which is involved in several physi-
ological events (12-14), and whose synthesis is mediated 
by NO synthase (NOS) activation. The effects of NO re-
quire the enhancement of the levels of nucleotide cyclic 
guanosine monophosphate (cGMP), a second messenger 
that activates protein kinase G (PKG), which promotes 
phosphorylation of proteins responsible for triggering the 
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effects of NO (15). 
The enzyme that produces NO is expressed in several 
tissues, including pituitary cells (16,17). Therefore, a con-
nection between the actions of Arg on the somatotrophs 
and NO production could exist. In fact, potent stimulators of 
GH secretion, such as growth hormone-releasing hormone 
(GHRH) and ghrelin, also exert their effects on the soma-
totrophs by the induction of NOS activity and, consequently, 
NO production (18,19). 
Although several studies have indicated that Arg induces 
GH secretion, less emphasis has been given to the effects 
of Arg on GH gene expression. 
Studies carried out in our laboratory indicated a role for 
Arg in GH gene expression, which was characterized by 
the increase of GH transcript content in rat pituitaries and 
GH3 cells 1 h after Arg treatment (20). However, the mecha-
nisms involved in this effect are still unknown. The present 
study attempted to investigate this issue by evaluating the 
involvement of NO signaling pathways in the Arg-induced 
GH gene expression, in isolated rat hemi-pituitaries.
Material and Methods
Materials
Arginine was kindly provided by Laboratórios Baldacci 
(Brazil). Ketamine and xylazine were purchased from Davol 
Comércio e Representações Ltda. (Brazil). Modified Eagle’s 
medium (MEM), phosphate-buffered saline (PBS), Nw-
nitro-L-arginine methyl ester (L-NAME), nifedipine, sodium 
nitroprusside (SNP), hemoglobin, and 8-bromoguanosine- 
3’:5’-cyclic monophosphate (8-Br-cGMP) were purchased 
from Sigma Chemical Co. (USA). Phenol, formamide, 
guanidine isothiocyanate, sodium N-lauryl sarcosine, diethyl 
pyrocarbonate (DEPC), salmon sperm DNA, DNase, aga-
rose, N-morpholino-propanesulfonic acid buffer (MOPS), 
sodium dodecyl sulfate, random primer labeling system 
kit, and ethidium bromide were purchased from Invitrogen 
Life Technology (USA). Films for X-ray, developer and 
replenisher were purchased from IBF (Indústria Brasileira 
de Filmes, Brazil). The MAXIscriptTM T3/T7 kit - In vitro 
RNA Transcription kit was purchased from Ambion (USA). 
Bovine serum albumin (BSA) and ß-mercaptoethanol were 
purchased from Life Technologies, Inc. (USA). High-quality 
nylon membranes were purchased from Bio-Rad Labo-
ratórios Brasil Ltda. (Brazil). [32P]-CTP and [32P]-UTP were 
purchased from PerkinElmer do Brasil Ltda. (Brazil). All other 
reagents were purchased from Labsynth (Brazil).
Animals and treatments
Male Wistar rats weighing approximately 250 g obtained 
from our own breeding colony were used in the experiments. 
The animals were housed under conditions of constant 
temperature (23 ± 1°C) on a 12 h-light, 12-h dark (lights 
on at 7:00 am) schedule. Standard rat chow and tap water 
were provided ad libitum. The pituitaries from these animals 
were used for the studies, as described below. All experi-
ments were performed in the morning between 9:00 and 
11:00 am and repeated three times at the same time of 
day. The experimental protocols are in accordance with 
the ethical principles in animal research adopted by the 
Brazilian College of Animal Experimentation (COBEA) 
and were approved by the Ethics Committee of Instituto 
de Ciências Biomédicas, Universidade de São Paulo, 
for Animal Research (CEEA). Before the experiments, 
the animals were weighed, anesthetized, and killed by 
decapitation. 
The experimental protocol used was adapted from 
Bianco et al. (21) and Hefco et al. (22), and the modifica-
tions are described below. The pituitaries were excised 
by an aseptic technique, washed once in 1X PBS, and 
sectioned longitudinally in two halves. Each half was placed 
on 2 different plates, and 2 pools of 3 hemi-pituitaries each 
were prepared. One pool was used for the control group 
and the other for the experimental groups. Subsequently, 
hemi-pituitaries were pre-incubated in 1 mL MEM under 
controlled conditions (95% O2 and 5% CO2 at 37°C). 
After 30 min, the medium was removed and replaced 
with MEM containing saline or different compounds, 
such as 71 mM Arg, 55 mM L-NAME, 3 µM nifedipine, 10 
nM, 1 µM, 0.1 mM, and 1 mM SNP, 0.3 µM hemoglobin, 
and 0.1 and 1 mM 8-Br-cGMP for 60 min. At the end of 
incubation, the medium was removed once again and the 
hemi-pituitaries were subjected to total RNA extraction. The 
dose of Arg used in the experiments was chosen from the 
dose-response (7.1, 71, 710 mM) and time-course study 
(10, 20, 30, 60, and 120 min). Each experiment included 
3 rats per group and was repeated three times.
Total RNA extraction and Northern blotting analysis
Total RNA was isolated using the acid guanidinium 
thiocyanate-phenol-chloroform extraction method (23) 
and quantified by absorbance at 260 nm. Total RNA 
samples were denatured with formaldehyde-formamide 
and submitted to electrophoresis on 1% agarose gels 
containing 2.2 M formaldehyde in 1X MOPS and blotted 
to a nylon membrane by neutral capillary transfer. The 
membrane was dried at 80°C for 1 h in a vacuum oven 
and pre-hybridized in 50% formamide hybridization solution 
and 100 g/mL denatured salmon sperm DNA at 42°C for 
4 h. Subsequently, the membrane was incubated with a 
[32P]-labeled rat GH cDNA by random priming for 16 h at 
42°C. The membrane was washed under high-stringency 
conditions, subjected to autoradiography and quantified 
by phosphor imaging using the ImageQuant software 
(Molecular Dynamics, USA). All membranes were stripped 
and re-hybridized with a [32P]-labeled RNA probe specific 
for 18S ribosomal RNA (18S c-rRNA), synthesized by in 
vitro transcription, to correct the variability in RNA loading. 
The results are reported as means ± SEM GH mRNA/18S 
rRNA ratio. 
1068 S.C.F. Olinto et al.
www.bjournal.com.brBraz J Med Biol Res 45(11) 2012
Statistical analysis
Data are reported as means ± SEM and were subjected 
to analysis of variance (ANOVA) followed by the Student- 
Newman-Keuls test. The Student t-test was applied when 
appropriate. The level of significance was established at 
5% (P < 0.05). 
Results
Effect of different doses of arginine on GH mRNA 
expression
Figure 1 shows the GH mRNA response of hemi-pitu-
itaries to 7.1, 71, 710 mM Arg added to the culture medium 
for 60 min. It can be seen that 7.1 mM Arg did not change 
GH mRNA content compared to control. However, a 10 
times higher dose of Arg (71 mM) led to an increase in GH 
transcript level. In contrast, a 100 times higher dose of Arg 
(710 mM) did not alter GH mRNA content, which remained 
similar to control. Therefore, the subsequent experiments 
in which the effect of Arg was tested were performed using 
the dose of 71 mM.
Time-course study of GH gene expression in 
response to arginine
Considering that GH mRNA content was shown to be 
increased 60 min after the hemi-pituitaries were incubated 
with 71 mM Arg, in the present study we evaluated the effect 
of this dose of Arg on this parameter during shorter (10, 20, 
and 30 min) periods of time and periods longer than 60 min 
(120 min). Figure 2 shows these data, which demonstrate 
that GH mRNA content was not altered 10, 20, and 30 min 
after Arg treatment. However, when the time of incubation 
was extended to 120 min, a significant increase of GH mRNA 
content was observed. This result indicates that, from 60 min 
to at least 120 min of Arg incubation, the GH mRNA content 
remained increased; hence, in the subsequent experiments, 
we decided to use the shorter period of time during which 
this dose of Arg led to the increase of GH mRNA. 
Arginine induces GH mRNA expression through NO 
generation 
To evaluate the involvement of NO in the Arg-induced 
GH mRNA expression, we added an L-NAME, a known NOS 
inhibitor, to the culture medium for the hemi-pituitaries in 
the presence or absence of Arg. These data are presented 
in Figure 3, which shows that L-NAME by itself did not alter 
GH gene expression; however, when associated with Arg, 
this compound prevented the increase of GH transcript 
content induced by the amino acid.
NO increases GH mRNA expression
To determine whether NO increases GH mRNA expres-
sion, hemi-pituitaries were incubated with SNP, a well-known 
NO donor, at the following concentrations: 1 mM, 0.1 mM, 
1 µM, and 10 nM. Figure 4A illustrates this experiment, and 
shows that SNP was able to increase GH mRNA expression 
at the higher concentrations used (1 and 0.1 mM). However, 
when hemoglobin, which is an NO acceptor, was added to 
the culture medium concomitantly with SNP, the effect of 
the latter in increasing GH mRNA content was abrogated 
(Figure 4B).
Considering that the actions of NO are mediated by 
cGMP, a stable analogue of 8-Br-cGMP (1 mM) was added 
to the hemi-pituitary culture medium to evaluate GH mRNA 
expression. As shown in Figure 4C, 8-Br-cGMP led to an 
increase of GH gene expression, an effect that was com-
Figure 1. Dose-response study of the effect of arginine on growth hormone (GH) mRNA expression. A, Typical autoradiograms of 
the GH mRNA and 18S abundance obtained in one experiment of a total of three. B, Quantitative representation of hybridization of 
GH and 18S rRNA transcripts obtained in all experiments. Hemi-pituitaries were incubated for 1 h with saline (S) or arginine (A) at 
the concentrations of 7.1, 71, and 710 mM. The values obtained from blot densitometry were normalized by 18S rRNA. Data are 
reported as means ± SEM in arbitrary units (AU). *P < 0.01 vs all other groups (one-way ANOVA followed by the Student-Newman-
Keuls test).
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Figure 2. Time-course study of the effect of arginine on growth hormone (GH) mRNA expression. Panels A, B, C, and D present 
at the top typical autoradiograms of the GH mRNA and 18S abundance obtained in one experiment of a total of three for hemi-
pituitaries treated with saline (S) or 71 mM arginine (A) for 10, 20, 30, and 120 min, respectively. The quantitative representation 
of hybridization of GH and 18S rRNA transcripts obtained in all experiments is shown at the bottom of each panel. Data are 
reported as means ± SEM in arbitrary units (AU). *P < 0.05 vs saline (Student t-test).
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Figure 3. Effect of L-NAME plus arginine administration on growth hormone (GH) mRNA expression. A, Typical autoradiograms of the GH 
mRNA and 18S abundance obtained in one experiment of a total of three. B, Quantitative representation of hybridization of GH and 18S rRNA 
transcripts obtained in all experiments. Hemi-pituitaries were incubated for 1 h with saline (S) or 71 mM arginine (A) in the presence or absence 
of 55 mM L-NAME (L-NAME and A+L-NAME). The values obtained from blot densitometry were normalized by 18S rRNA. Data are reported 
as means ± SEM in arbitrary units (AU). *P < 0.001 vs all other groups (one-way ANOVA followed by the Student-Newman-Keuls test).
Figure 4. Effect of nitric oxide on growth hormone (GH) gene 
expression. Panel A, Hemi-pituitaries incubated for 1 h with sa-
line (S) or sodium nitroprusside (SNP) at the following concentra-
tions: 10 nM, 1 µM, 0.1 mM, and 1 mM. Panel B, Hemi-pituitaries 
were incubated for 1 h with S or 0.1 mM SNP in the presence 
or absence of 0.3 µM hemoglobin (Hb and SNP+Hb). Panel C, 
Hemi-pituitaries incubated for 1 h with S or 8-Br-cGMP at the con-
centrations of 0.1 and 1 mM. Typical autoradiograms of the GH 
mRNA and 18S abundance obtained in one experiment of a total 
of three are shown at the top of each panel, and the quantitative 
representation of hybridization of GH and 18S rRNA transcripts 
obtained in all experiments is shown at the bottom of each panel. 
The values obtained from blot densitometry were normalized by 
18S rRNA. Data are reported as means ± SEM in arbitrary units 
(AU). A, *P < 0.05 vs S, 0.1 mM SNP and 1 mM SNP; B, *P < 
0.05 vs all other groups; C, *P < 0.05 vs all other groups (one-way 
ANOVA followed by the Student-Newman-Keuls test).
Arginine induces GH expression through NO signaling pathway 1071
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parable to those observed after Arg or SNP treatment.
Calcium is involved in arginine-induced GH mRNA 
expression
To evaluate whether Ca2+ is required for the effects of Arg 
on GH mRNA expression, an L-type Ca2+ channel blocker, 
nifedipine (3 µM), was added to the hemi-pituitary culture 
medium in the presence or absence of Arg. Figure 5 shows 
that the stimulatory effect of Arg on GH gene expression 
was completely abolished by nifedipine, whereas nifedipine 
alone had no effect on GH gene expression.
Discussion
Arginine is a conditionally essential amino acid that 
was shown to stimulate GH gene expression in in vivo 
and in vitro studies (20) by mechanisms that were poorly 
understood. In the present study, we used hemi-pituitaries 
of rats incubated in the presence of 71 mM Arg for 60 min, 
in an attempt to determine the mechanism that underlies 
this effect. This dose and time of incubation period were 
selected after detecting that Arg is able to increase GH 
mRNA content in a dose- and time-independent manner. For 
this reason, we chose only one dose of Arg and the shortest 
time tested when its effect was observed. In fact, the use of 
a 10 times higher dose of Arg (710 mM) led to a decrease in 
GH transcript amount compared to the results obtained with 
71 mM Arg. It is known that high concentrations of arginine 
may generate high concentrations of NO, and the excess 
of NO and, as described (24), its derivatives might be as-
sociated with the inhibition of mitochondrial respiration, a 
mechanism that could affect GH gene expression. 
Arg is the natural precursor of NO, whose generation 
depends on the activity of NOS, an enzyme expressed in 
many tissues, including the pituitary cells (25), that catalyzes 
the oxidation of Arg to citrulline and NO (26). NO acts as an 
intracellular and intercellular mediator in many physiological 
processes (15), and it was shown to be implicated in the 
regulation of the activity of the hypothalamus-pituitary axis. 
NO can also regulate the expression of many genes, like 
the CYP4A in liver and kidney (27) and glial fibrillary acidic 
protein (GFAP) in astrocytes (28), and an involvement of 
NOS and NO in the enhancement of GH gene expression 
by Arg was also pointed in the current study.
Indeed, the inhibition of NOS activity by the addition of 
L-NAME to the hemi-pituitaries incubated in the presence 
of Arg prevented its stimulatory effect on GH gene expres-
sion, indicating that the products generated by NOS were 
mediating the increase of the GH mRNA content. As already 
mentioned, the main product generated from NOS activity 
is NO, which exerts important actions on the pituitaries, 
such as the induction of GH secretion (18,19). Therefore, 
it is possible that NO may enhance GH gene expression, 
since the effects of Arg increasing GH mRNA content were 
abolished by L-NAME, as pointed out here. 
The addition of SNP, a potent NO donor, to the hemi-
pituitary incubation medium also increased GH gene 
expression, providing evidence of a direct effect of NO, 
which is supposed to be the main metabolite involved in 
the Arg-induced GH gene expression. Moreover, the con-
comitant addition of SNP and hemoglobin, which is an NO 
acceptor, abrogated the increase of GH mRNA induced 
by SNP alone, reinforcing the role of NO in the control of 
somatotroph GH gene expression. 
Our data agree with reports indicating a stimulatory ef-
fect of GHRH or ghrelin on GH secretion, which relies on 
Figure 5. Effect of nifedipine plus arginine on GH gene expression. A, Typical autoradiograms of the GH mRNA and 18S abundance 
obtained in one experiment of a total of three. B, Quantitative representation of hybridization of GH and 18S rRNA transcripts ob-
tained in all experiments. Hemi-pituitaries were incubated for 1 h with saline (S) or 71 mM arginine (A) in the presence or absence 
of 3 µM nifedipine (N and A+N). The values obtained from blot densitometry were normalized by 18S rRNA. Data are reported as 
means ± SEM in arbitrary units (AU). *P < 0.05 vs all other groups (one-way ANOVA followed by the Student-Newman-Keuls test).
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the activation of NOS and NO production (18,19). Since 
GHRH is the most important stimulator of GH synthesis 
and secretion, and NO is involved in the GHRH signaling 
pathway, our findings strongly indicate that NO might con-
trol the function of somatotrophs, regulating the GH gene 
expression as well. Evidence of a role of NO in the control 
of GH gene expression was also suggested by studies 
showing that leptin regulates GH gene expression and also 
stimulates NO release in pig pituitary cells (25).
To exert its effects, NO needs to recruit and activate 
guanylate cyclase, an enzyme that converts guanosine 
triphosphate (GTP) to cGMP. cGMP is a second messenger 
that binds to PKG, leading to conformational changes in 
its structure, and, as a consequence, to its activation. This 
enzyme is responsible for the actions of NO on the organic 
system (29); hence, the effects of NO on cells are associated 
with increased intracellular cGMP content (30). 
This rationale was used in the experiment in which 
hemi-pituitaries were incubated with 8-Br-cGMP, a cGMP 
analogue, which may mimic the actions of NO (18). 8-Br-
cGMP definitely led to an increase in GH mRNA content, 
indicating that the components of the NO signaling pathway 
are indeed involved in this mechanism. 
In the present study, calcium ion was also shown to be 
involved in the effects of Arg on somatotrophs, since the 
inhibition of its influx into pituitaries by nifedipine prevented 
the stimulatory effect of Arg on GH gene expression. Even 
though the precise mechanism by which calcium is impli-
cated in this response is unknown, it is recognized that 
calcium is an inductor of NOS activity, consequently leading 
to an increase in NO (31). However, other mechanisms 
could be activated by calcium. It is known that calcium influx 
through L-type voltage-gated calcium channels is required 
for the expression of specific genes. Indeed, the increase 
of intracellular Ca2+ concentration was shown to lead to the 
activation of cyclic AMP-responsive element binding protein 
(CREB), and subsequently to the induction of somatostatin 
gene expression (32). 
In fact, it is well known that GHRH stimulates GH gene 
expression through cAMP-mediated protein kinase A, which 
phosphorylates and activates CREB (33). As mentioned 
above, one of the best characterized signals for CREB 
phosphorylation and activation is an increase in intracellular 
Ca2+ concentrations (32,34). Activated CREB is known to 
enhance Pit-1 gene transcription, and, as a consequence, to 
enhance GH gene expression (35). Definitely, the presence 
of calcium is essential for the action of Arg on somatotrophs, 
such as GH release and GH gene expression.
Taken together, the present data indicate a clear and 
direct effect of the amino acid Arg on the increase of GH 
mRNA content by means of NO generation, because 
L-NAME was able to prevent the increase of GH gene 
expression. NO is known to increase cGMP, and this study 
also showed that NO donors, as well as cGMP, which is 
supposed to mediate the effects of NO, increase GH gene 
expression. Calcium entry appeared to be necessary for 
the induction of GH gene expression by Arg. Hence, in 
parallel to its recognized effect on GH release, Arg also 
increases GH gene expression by activating the NOS/
NO signaling pathway. These data increase the body of 
evidence showing that dietary constituents can modulate 
events that regulate gene expression, therefore affecting 
specific aspects of cellular function.
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